Janus Henderson Global Life Sciences Fund I2 USD
IE0002141913
Janus Henderson Global Life Sciences Fund I2 USD/ IE0002141913 /
NAV12/19/2024 |
Chg.-0.4000 |
Type of yield |
Investment Focus |
Investment company |
63.2800USD |
-0.63% |
reinvestment |
Equity
Worldwide
|
Janus Henderson Inv. ▶ |
Investment strategy
The Fund aims to provide capital growth over the long term. Performance target: To outperform the MSCI World Health Care Index by at least 2% per annum, before the deduction of charges, over any 5 year period.
The Fund invests at least 80% in shares (also known as equities) of companies, of any size, including smaller capitalisation companies, with a life sciences orientation, in any country. Up to 20% may be invested in developing markets. The Fund may also invest in other assets including cash and money market instruments. The Sub-Investment Adviser may use derivatives (complex financial instruments) to reduce risk, to manage the Fund more efficiently, or to generate additional capital or income for the Fund. The Fund is actively managed with reference to the MSCI World Health Care Index, which is broadly
Investment goal
The Fund aims to provide capital growth over the long term. Performance target: To outperform the MSCI World Health Care Index by at least 2% per annum, before the deduction of charges, over any 5 year period.
Master data
Type of yield: |
reinvestment |
Funds Category: |
Equity |
Region: |
Worldwide |
Branch: |
Sector Health / Pharma |
Benchmark: |
MSCI World Health Care Index |
Business year start: |
1/1 |
Last Distribution: |
- |
Depository bank: |
J.P. Morgan SE, Dublin Branch |
Fund domicile: |
Ireland |
Distribution permission: |
Austria, Germany, Switzerland, United Kingdom |
Fund manager: |
Andy Acker, Daniel Lyons |
Fund volume: |
3.79 bill.
USD
|
Launch date: |
3/31/2000 |
Investment focus: |
- |
Conditions
Issue surcharge: |
2.00% |
Max. Administration Fee: |
1.50% |
Minimum investment: |
1,000,000.00 USD |
Deposit fees: |
- |
Redemption charge: |
0.00% |
Key Investor Information: |
Download (Print version) |
Investment company
Funds company: |
Janus Henderson Inv. |
Address: |
201 Bishopsgate, EC2M 3AE, London |
Country: |
United Kingdom |
Internet: |
www.janushenderson.com/
|
Assets
Stocks |
|
99.03% |
Cash |
|
0.96% |
Others |
|
0.01% |
Countries
United States of America |
|
74.83% |
Denmark |
|
5.50% |
United Kingdom |
|
3.50% |
Switzerland |
|
3.30% |
France |
|
2.52% |
Ireland |
|
2.16% |
Netherlands |
|
2.13% |
Virgin Islands (British) |
|
0.99% |
Cash |
|
0.96% |
Israel |
|
0.95% |
Japan |
|
0.62% |
China |
|
0.51% |
Cayman Islands |
|
0.44% |
Canada |
|
0.28% |
Others |
|
1.31% |
Branches
Pharma/Biotechnology |
|
62.49% |
Healthcare services |
|
16.60% |
Healthcare appliances |
|
16.19% |
Parma, wholesale |
|
1.83% |
Cash |
|
0.96% |
Gesundheitswesen/ Informationstechnologie |
|
0.60% |
Others |
|
1.33% |